Furusawa S, Nomoto H, Yokoyama H, Suzuki Y, et al. Glycaemic control efficacy of switching from dipeptidyl peptidase-4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 2 study). Diabetes Obes Metab 2023 Dec 11. doi: 10.1111/dom.15393.
PMID: 38073422